Selective serotonin reuptake inhibitors and adjuvant tamoxifen therapy: risk of breast cancer recurrence and mortality

التفاصيل البيبلوغرافية
العنوان: Selective serotonin reuptake inhibitors and adjuvant tamoxifen therapy: risk of breast cancer recurrence and mortality
المؤلفون: Henrik Toft Sørensen, Deirdre Cronin-Fenton, Timothy L. Lash
المصدر: Cronin-Fenton, D, Lash, T L & Sørensen, H T 2010, ' Selective serotonin reuptake inhibitors and adjuvant tamoxifen therapy: risk of breast cancer recurrence and mortality ', Future Oncology, vol. 6, no. 6, pp. 877-80 . https://doi.org/10.2217/fon.10.65Test
بيانات النشر: Future Medicine Ltd, 2010.
سنة النشر: 2010
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Neoplasms, Hormone-Dependent, Antineoplastic Agents, Hormonal, Denmark, Breast Neoplasms, Citalopram, Recurrence, Cytochrome P-450 CYP2D6 Inhibitors, Internal medicine, medicine, Humans, Drug Interactions, Alleles, Biotransformation, Adjuvant tamoxifen, Depression, business.industry, Breast cancer recurrence, Estrogens, General Medicine, Serotonin reuptake, Prognosis, Tamoxifen, Cytochrome P-450 CYP2D6, Serotonin Uptake Inhibitors, Female, business, Selective Serotonin Reuptake Inhibitors
الوصف: Udgivelsesdato: 2010-Jun
تدمد: 1744-8301
1479-6694
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a767bd56cb52f486b75c824f7624683Test
https://doi.org/10.2217/fon.10.65Test
حقوق: RESTRICTED
رقم الانضمام: edsair.doi.dedup.....4a767bd56cb52f486b75c824f7624683
قاعدة البيانات: OpenAIRE